New naturally occurring missense mutations of the human mineralocorticoid receptor disclose important residues involved in dynamic interactions with deoxyribonucleic acid, intracellular trafficking, and ligand binding

Molecular Endocrinology

Volumn 18, Issue 9, 2004, Pages 2151-2165

  Sartorato, Paola ^a,b   Cluzeaud, Françoise ^a   Fagart, Jérôme ^a   Viengchareun, Say ^a   Lombès, Marc ^a   Zennaro, Maria Christina ^a  

^a INSERM   (France)

^b Ospedale 105   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MINERALOCORTICOID RECEPTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BINDING AFFINITY; CELLULAR DISTRIBUTION; CLUSTER ANALYSIS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA BINDING; DNA TRANSCRIPTION; HYDROPHOBICITY; MISSENSE MUTATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PSEUDOHYPOALDOSTERONISM; SPORADIC TYPE 1 PSEUDOHYPOALDOSTERONISM; THREE DIMENSIONAL IMAGING; TRANSACTIVATION;

ALDOSTERONE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CELL NUCLEUS; CELLS, CULTURED; DNA; HUMANS; INTRACELLULAR SPACE; KIDNEY TUBULES, COLLECTING; LIGANDS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROTEIN CONFORMATION; PROTEIN TRANSPORT; PSEUDOHYPOALDOSTERONISM; RABBITS; RECEPTORS, MINERALOCORTICOID; TRANS-ACTIVATION (GENETICS);

ANIMALIA;

EID: 4544376911     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0408     Document Type: Article

References (56)

1. Verrey F, Pearce D, Pfeiffer R, Spindler B, Mastroberardino L, Summa V, Zecevic M 2000 Pleiotropic action of aldosterone in epithelia mediated by transcription and post-transcription mechanisms. Kidney Int 57:1277-1282
2. Lifton RP, Gharavi AG, Geller DS 2001 Molecular mechanisms of human hypertension. Cell 104:545-556
3. Zennaro M-C, Armanini D, Mantero F 1999 Mineralocorticoid resistance. Topical Endocrinol 12:2-6
4. Geller DS, Rodriguez-Soriano J, Vallo Boado A, Schifter S, Bayer M, Chang SS, Lifton RP 1998 Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet 19:279-281
5. Tajima T, Kitagawa H, Yokoya S, Tachibana K, Adachi M, Nakae J, Suwa S, Katoh S, Fujieda K 2000 A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1. J Clin Endocrinol Metab 85:4690-4694
6. Viemann M, Peter M, Lopez-Siguero JP, Simic-Schleicher G, Sippell WG 2001 Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds. J Clin Endocrinol Metab 86:2056-2059
7. Sartorato P, Lapeyraque AL, Armanini D, Kuhnle U, Khaldi Y, Salomon R, Abadie V, Di Battista E, Naselli A, Racine A, Bosio M, Caprio M, Poulet-Young V, Chabrolle JP, Niaudet P, De Gennes C, Lecornec MH, Poisson E, Fusco AM, Loli P, Lombes M, Zennaro MC 2003 Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism. J Clin Endocrinol Metab 88:2508-2517
8. Sartorato P, Khaldi Y, Lapeyraque AL, Armanini D, Kuhnle U, Salomon R, Caprio M, Viengchareun S, Lombes M, Zennaro MC 2004 Inactivating mutations of the mineralocorticoid receptor in type I pseudohypoaldosteronism. Mol Cell Endocrinol 217:119-125
9. Riepe FG, Krone N, Morlot M, Ludwig M, Sippell WG, Partsch CJ 2003 Identification of a novel mutation in the human mineralocorticoid receptor gene in a German family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity. J Clin Endocrinol Metab 88:1683-1686
10. Nuclear Receptor Committee 1999 A unified nomenclature system for the nuclear receptor superfamily. Cell 97:161-163
11. Pratt WB 1997 The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu Rev Pharmacol Toxicol 37:297-326
12. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
13. Kitagawa H, Yanagisawa J, Fuse H, Ogawa S, Yogiashi Y, Okuno A, Nagasawa H, Nakajima T, Matsumoto T, Kato S 2002 Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex. Mol Cell Biol 22:3698-3706
14. Tallec LP, Kirsh O, Lecomte MC, Viengchareun S, Zennaro MC, Dejean A, Lombes M 2003 Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification. Mol Endocrinol 17:2529-2542
15. Rogerson FM, Fuller PJ 2003 Interdomain interactions in the mineralocorticoid receptor. Mol Cell Endocrinol 200:45-55
16. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268-275
17. Williams SP, Sigler PB 1998 Atomic structure of progesterone complexed with its receptor. Nature 393:392-396
18. Matias PM, Donner P, Coelho R, Thomaz M, Peixoto C, Macedo S, Otto N, Joschko S, Scholz P, Wegg A, Basler S, Schafer M, Egner U, Carrondo MA 2000 Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. J Biol Chem 275:26164-26171
19. Sack JS, Kish KF, Wang C, Attar RM, Kiefer SE, An Y, Wu GY, Scheffler JE, Salvati ME, Krystek Jr SR, Weinmann R, Einspahr HM 2001 Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proc Natl Acad Sci USA 98:4904-4909
20. Kauppi B, Jakob C, Farnegardh M, Yang J, Ahola H, Alarcon M, Calles K, Engstrom O, Harlan J, Muchmore S, Ramqvist AK, Thorell S, Ohman L, Greer J, Gustafsson JA, Carlstedt-Duke J, Carlquist M 2003 The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism. J Biol Chem 278:22748-22754
21. Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM, Lambert MH, Moore JT, Pearce KH, Xu HE 2002 Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110:93-105
22. Fagart J, Wurtz JM, Souque A, Hellal-Levy C, Moras D, Rafestin-Oblin ME 1998 Antagonism in the human mineralocorticoid receptor. EMBO J 17:3317-3325
23. Auzou G, Fagart J, Souque A, Hellal-Levy C, Wurtz JM, Moras D, Rafestin-Oblin ME 2000 A single amino acid mutation of ala-773 in the mineralocorticoid receptor confers agonist properties to 11β-substituted spirolactones. Mol Pharmacol 58:684-691
24. Rogerson FM, Brennan FE, Fuller PJ 2003 Dissecting mineralocorticoid receptor structure and function. J Steroid Biochem Mol Biol 85:389-396
25. Zennaro MC, Keightley MC, Kotelevtsev Y, Conway G, Soubrier F, Fuller PJ 1995 Human mineralocorticoid receptor genomic structure and identification of expressed isoforms. J Biol Chem 270:21016-21020
26. Zennaro MC, Farman N, Bonvalet J-P, Lombes M 1997 Tissue-specific expression of α and β messenger ribonucleic acid isoforms of the human mineralocorticoid receptor in normal and pathological states. J Clin Endocrinol Metab 82:1345-1352
27. Zennaro MC, Le Menuet D, Lombès M 1996 Characterization of the human mineralocorticoid receptor gene 5′-regulatory region: evidence for differential hormonal regulation of two alternative promoters via non-classical mechanisms. Mol Endocrinol 10:1549-1560
28. Le Menuet D, Viengchareun S, Penfornis P, Walker F, Zennaro MC, Lombes M 2000 Targeted oncogenesis reveals a distinct tissue-specific utilization of alternative promoters of the human mineralocorticoid receptor gene in transgenic mice. J Biol Chem 275:7878-7886
29. Bloem LJ, Quo C, Pratt JH 1995 Identification of a splice variant of the rat and human mineralocorticoid receptor genes. J Steroid Biochem Mol Biol 55:159-162
30. Zhou MY, Gomez-Sanchez CE, Gomez-Sanchez EP 2000 An alternatively spliced rat mineralocorticoid receptor mRNA causing truncation of the steroid binding domain. Mol Cell Endocrinol 159:125-131
31. Zennaro MC, Souque A, Viengchareun S, Poisson E, Lombes M 2001 A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action. Mol Endocrinol 15:1586-1598
32. Lombes M, Kenouch S, Souque A, Farman N, Rafestin-Oblin M-E 1994 The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11 β-hydroxysteroid dehydrogenase. Endocrinology 135:834-840
33. Rigaud G, Roux J, Pictet R, Grange T 1991 In vivo foot-printing of rat TAT gene: dynamic interplay between the glucocorticoid receptor and a liver-specific factor. Cell 67:977-986
34. McNally JG, Muller WG, Walker D, Wolford R, Hager GL 2000 The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 287:1262-1265
35. Couette B, Jalaguier S, Hellal-Levy C, Lupo B, Fagart J, Auzou G, Rafestin-Oblin ME 1998 Folding requirements of the ligand-binding domain of the human mineralocorticoid receptor. Mol Endocrinol 12:855-863
36. Hellal-Levy C, Fagart J, Souque A, Wurtz JM, Moras D, Rafestin-Oblin ME 2000 Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor. Mol Endocrinol 14:1210-1221
37. Deppe CE, Heering PJ, Viengchareun S, Grabensee B, Farman N, Lombes M 2002 Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. Endocrinology 143:1932-1941
38. Fejes-Toth G, Pearce D, Naray-Fejes-Toth A 1998 Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists. Proc Natl Acad Sci USA 95:2973-2978
39. Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler PB 1991 Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352:497-505
40. Nagaich AK, Walker DA, Wolford R, Hager GL 2004 Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling. Mol Cell 14:163-174
41. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852
42. Hager GL, Lim CS, Elbi C, Baumann CT 2000 Trafficking of nuclear receptors in living cells. J Steroid Biochem Mol Biol 74:249-254
43. DeFranco DB 2002 Navigating steroid hormone receptors through the nuclear compartment. Mol Endocrinol 16:1449-1455
44. Pearce D, Naray-Fejes-Toth A, Fejes-Toth G 2002 Determinants of subnuclear organization of mineralocorticoid receptor characterized through analysis of wild type and mutant receptors. J Biol Chem 277:1451-1456
45. Cokol M, Nair R, Rost B 2000 Finding nuclear localization signals. EMBO Rep 1:411-415
46. Sackey FN, Hache RJ, Reich T, Kwast-Welfeld J, Lefebvre YA 1996 Determinants of subcellular distribution of the glucocorticoid receptor. Mol Endocrinol 10:1191-1205
47. Hache RJ, Tse R, Reich T, Savory JG, Lefebvre YA 1999 Nucleocytoplasmic trafficking of steroid-free glucocorticoid receptor. J Biol Chem 274:1432-1439
48. Tyagi RK, Amazit L, Lescop P, Milgrom E, Guiochon-Mantel A 1998 Mechanisms of progesterone receptor export from nuclei: role of nuclear localization signal, nuclear export signal, and ran guanosine triphosphate. Mol Endocrinol 12:1684-1695
49. Black BE, Holaska JM, Rastinejad F, Paschal BM 2001 DNA binding domains in diversem u clear receptors function as nuclear export signals. Curr Biol 11:1749-1758
50. Htun H, Holth LT, Walker D, Davie JR, Hager GL 1999 Direct visualization of the human estrogen receptor a reveals a role for ligand in the nuclear distribution of the receptor. Mol Biol Cell 10:471-486
51. Fagart J, Hellal-Levy C, Souque A, Rafestin-Oblin ME 2002 Molecular basis of ligand recognition by the mineralocorticoid and glucocorticoid receptors. In: Demonacos MK-DC, ed. Molecular mechanisms of action of steroid hormone receptors. Kerala, India: Research Sign-post; 77-85
52. Tahiri B, Auzou G, Nicolas JC, Sultan C, Lupo B 2001 Participation of critical residues from the extreme C-terminal end of the human androgen receptor in the ligand binding function. Biochemistry 40:8431-8437
53. Massaad C, Houard N, Lombes M, Barouki R 1999 Modulation of human mineralocorticoid receptor function by protein kinase A. Mol Endocrinol 13:57-65
54. Vandewalle A, Lelongt B, Geniteau-Legendre M, Baudouin B, Antoine M, Estrade S, Chatelet F, Verroust P, Cassingena R, Ronco P 1989 Maintenance of proximal and distal cell functions in SV40-transformed tubular cell lines derived from rabbit kidney cortex. J Cell Physiol 141:203-221
55. Prie D, Friedlander G, Coureau C, Vandewalle A, Cassigena R, Ronco PM 1995 Role of adenosine on glucagon-induced cAMP in human collecting duct cell line. Kidney Int 47:1310-1318
56. Jones TA, Zou JY, Cowan SW, Kjeldgaard 1991 Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 47:110-119